Clinical Trial Search block Test
Noninvasive Biomarkers of Hepatic Fibrosis in Urea Cycle Disorders
UCDC Liver Study
What is the goal of the study?
Primary Study Objective: To assess risk for increased fibrosis using serum biomarkers and/or patented vibration-controlled transient elastography technology (VCTE using Fibroscan®) in distal disorders (argininosuccinate synthetase deficiency or ASS1D, argininosuccinate lyase deficiency or ASLD, and arginase deficiency or ARG1D) as compared to ornithine transcarbamylase deficiency (OTCD)
Who can participate in the study?
Everyone